ADVANCE FOR WEDNESDAY NOV 18; chart shows pharmaceutical sales growth
ADVANCE FOR WEDNESDAY NOV 18; graphic shows market share for leading vaccine manufacturers
ADVANCE FOR WEDNESDAY NOV 18; graphic shows vaccine revenue since 2004 and revenue growth by vaccine
FILE - In this undated photo provided by Sanofi Pasteur, technicians perform production operations during a dry run at the company's influenza manufacturing facility in Swiftwater, Pa. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Sanofi Pasteur, David W. Coulter) NO SALES
FILE - In this Monday Oct. 26, 2009 file photo, Joseph Hartstein receives the swine flu vaccination at the local health authority in Dusseldorf, western Germany. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Frank Augstein, File)
FILE - In this Tuesday, Oct. 6, 2009 file photo, Amparo Martinez, left, watches as her daughter, Sorayo Martinez, 4, is given a dose of swine flu vaccine in Oregon City, Ore. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Don Ryan, File)
FILE - In this undated photo provided by Sanofi Pasteur, technicians perform production operations during a dry run at the company's influenza manufacturing facility in Swiftwater, Pa. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Sanofi Pasteur, David W. Coulter) NO SALES
FILE - In this Monday Oct. 26, 2009 file photo, Joseph Hartstein receives the swine flu vaccination at the local health authority in Dusseldorf, western Germany. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Frank Augstein, File)
FILE - In this Tuesday, Oct. 6, 2009 file photo, Amparo Martinez, left, watches as her daughter, Sorayo Martinez, 4, is given a dose of swine flu vaccine in Oregon City, Ore. Long seen as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and other deals to develop and manufacture in vaccines is on a tear, seen as a crucial new path to growth. (AP Photo/Don Ryan, File)
Leave your notes and wishes for the deployed Wyomingites.
© Copyright 2009, trib.com, Casper, WY | Terms of Service and Privacy Policy
